Stockscreener 앱 받기
1.22
2.52%
0.03
시간 외 거래:
1.23
0.01
+0.82%
전일 마감가:
$1.19
열려 있는:
$1.18
하루 거래량:
312.24K
Relative Volume:
1.53
시가총액:
$100.83M
수익:
-
순이익/손실:
$-21.65M
주가수익비율:
-3.6736
EPS:
-0.3321
순현금흐름:
$-15.84M
1주 성능:
-8.27%
1개월 성능:
-1.61%
6개월 성능:
-0.81%
1년 성능:
-41.63%
1일 변동 폭
$1.17
$1.23
1주일 범위
$1.14
$1.3493
52주 변동 폭
$0.7709
$2.63
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
명칭
Cardiol Therapeutics Inc
전화
-
주소
-
CRDL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.22 | 109.92M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
147.37 | 69.30B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 47.50B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.53 | 44.47B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.31 | 18.83B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
293.12 | 13.43B | 2.99B | 1.21B | 1.13B | 25.06 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 개시 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-06-26 | 개시 | ROTH MKM | Buy |
| 2024-04-22 | 개시 | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc 주식(CRDL)의 최신 뉴스
What analysts say about Cardiol Therapeutics Inc. stockTremendous financial leverage - Autocar Professional
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - news.stocktradersdaily.com
What drives Cardiol Therapeutics Inc. stock pricePowerful market insights - Autocar Professional
Cardiol Therapeutics Inc. Stock Analysis and ForecastTriple returns potential - Autocar Professional
Is Cardiol Therapeutics Inc. a good long term investmentMarket-leading capital gains - Autocar Professional
(CRDL) Investment Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (NASDAQ:CRDL) Shares Down 8.5% – Here’s What Happened - Defense World
Cardiol Therapeutics shares rise 3.88% premarket after CMS achieves secondary listing on Singapore Exchange. - AInvest
Why Cardiol Therapeutics Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser
How Cardiol Therapeutics Inc. stock performs during market volatilityFree Short-Term Stock Picks - Newser
What makes Cardiol Therapeutics Inc. stock price move sharplyBreakout Momentum Alerts - Newser
(CRDL) On The My Stocks Page (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Stock Market Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (OTCMKTS:CRTPF) Trading Up 10.8% – Still a Buy? - Defense World
Cardiol Therapeutics (TSE:CRDL) Trading Up 1% – Here’s Why - Defense World
(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Technical Patterns and Signals (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (TSE:CRDL) Trading Up 2.1% – Here’s What Happened - Defense World
(CRDL) Financial Trading Report (CRDL:CA) - news.stocktradersdaily.com
Analysts Issue Forecasts for CRDL Q2 Earnings - Defense World
All Eyes On ARCHER: Will Cardiol's Drug For Heart Muscle Inflammation Hit The Mark? - RTTNews
Cetera Investment Advisers Takes $56,000 Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World
This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
HC Wainwright & Co. Initiates Coverage of Cardiol Therapeutics (CRDL) with Buy Recommendation - Nasdaq
Cardiol Therapeutics (CRDL): HC Wainwright & Co. Initiates Coverage with a Buy Rating and $9 Price Target | CRDL Stock News - GuruFocus
H.C. Wainwright Initiates Coverage on Cardiol Therapeutics (CRDL) With Positive Outlook | CRDL Stock News - GuruFocus
(CRDL) Strategic Investment Guide (CRDL:CA) - news.stocktradersdaily.com
RAD Reports Positive Preclinical Lu177-B7H3-mAb Data - Investing News Network
Former Eli Lilly CMO Joins Cardiol’s Board, Bolstering Drug Development, Clinical Trial, and Commercial Expertise - SECFilings.com
Cardiol Therapeutics Announces AGM Results and New Board Member - TipRanks
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders | CRDL Stock News - GuruFocus
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders - Newsfile
Ex-Eli Lilly Chief Medical Officer Strengthens Cardiol Board as Critical Phase III Trial Nears Completion - Stock Titan
Cardiol Therapeutics Reports Q1 2025 Financial Results - TipRanks
Cardiol Therapeutics to Webcast Virtual Annual General Meeting o - GuruFocus
(CRDL) Market Insights and Trading Signals (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Inc. - Baystreet.ca
Stocks In Play: Cardiol Therapeutics Inc. - Barchart.com
Cardiol Therapeutics to Webcast AGM Amidst Ongoing Clinical Trials - TipRanks
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT - Newsfile
Cardiol Therapeutics Inc (CRDL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.68%
자본화:
|
볼륨(24시간):